作为阿尔茨海默氏症病理生理学中的表观遗传调节剂:叙述性综述
Jingkai Tang1, Yiwei Zhang1, Yibing Wang1
1Department of Sport Rehabilitation, Tianjin University of Sport, Tianjin, People's Republic of China.
Journal of inflammation research
|November 17, 2025
概括
乳糖化是一种代谢修饰,在阿尔茨海默氏病 (AD) 发病过程中起着复杂的作用. 本综述探讨了乳化如何影响神经炎症和β-粉样蛋白病理,提供了对潜在的AD生物标志物和治疗点的见解.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是认知能力下降,粉样蛋白β斑块和神经纤维状结.
- 全球越来越多的老年人口给社会带来了AD的社会经济影响.
- 了解AD复杂的发病过程需要探索新的分子标记物和治疗点.
研究的目的:
- 审查当前关于阿尔茨海默氏病中乳化的文献.
- 总结乳糖化调节AD病理学的潜在机制.
- 为识别AD的新分子标记物和治疗点提供理论基础.
主要方法:
- 对研究乳糖化及其在阿尔茨海默病中的作用的文献综述.
- 对乳化对神经炎症和Aβ病理的影响现有研究的分析.
- 综合发现,阐明AD中乳糖化调节机制.
主要成果:
- 乳化是一种涉及乳酸合的翻译后修饰,与AD有关.
- 特定的乳化部位,如H4K12la和H3K18la,与神经炎症,微质激活和火死有关.
- 乳化在阿尔茨海默病中的作用是复杂的,并且取决于情境,对Aβ病理有不同的影响.
结论:
- 乳化成为阿尔茨海默氏症病原发生的一个重要因素.
- 对乳化机制的进一步研究可能会揭示AD的新型治疗策略和生物标志物.
- 了解乳糖的双重作用对于开发有效的AD治疗至关重要.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Histone Modification
15.9K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.9K
Histone Modification
4.4K
4.4K
Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K
Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782
Inheritance of Chromatin Structures
7.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.2K


